 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.

Current Price	$0.9411
Prev Close	$0.9611
Open	$0.99
Dividend Yield	0.00%
50-Day Moving Average	$0.8125
Beta	1.50
Avg. Volume	433,530.09
PE Ratio	-1.39

52-Week High	$1.52
52-Week Low	$0.58
Market Capitalization	$114.64M
EPS	-$0.6778
Price to Book	-5.55
Revenue Per Employee	$50,500.00
Enterprise Value/EBITDA	-1.22

SEEL Seelos Therapeutics Inc

About

Feed

Fundamentals

News